Current treatment options for chronic granulomatous disease

Bibliography

• ROOS D, DE BOER M, KURIBAYASHI F et al.: Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood (1996) 87(5):1663–1681.
   PubMed Web of Science ®Google Scholar
• REPINE JE, RASMUSSEN B, WHITE JG: An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips. Am. Clin. Pathol (1979) 71(5):582–585.
   PubMed Web of Science ®Google Scholar
• PERTICARARI S, PRESANI G, BANFI E: A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. I Immunol Methods (1994) 170(1):117–124.
   PubMed Web of Science ®Google Scholar
• KENNEY RT, MALECH HL, EPSTEIN ND, ROBERTS RL, LETO TL: Characterization of the p67Ph0x gene: genomic organization and restriction fragment length polymorphism analysis for prenatal diagnosis in chronic granulomatous disease. Blood (1993) 82(12):3739–3744.
   PubMed Web of Science ®Google Scholar
• CALE CM, JONES AM, GOLDBLATT D: Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin. Exp. Immunol (2000) 120:1–6.
   Web of Science ®Google Scholar
• LIESE JG, JENDROSSEK V, JANSSON A et al.: Chronic granulomatous disease in adults. Lancet (1996) 347(8996):220–223.
   PubMed Web of Science ®Google Scholar
• LIESE J, KLOOS S, JENDROSSEK V et al.: Chronic granulomatous disease (CGD): incidence of infections and complications in 39 patients. Ma Med. (1998) 35:CL65.
   Google Scholar
• BUDUNELI N, BAYLAS H, AKSU G, KUTUKCULER N: Prepubertal periodontitis associated with chronic granulomatous disease. Clin. Periodontol (2001) 28(6):589–593.
   PubMed Web of Science ®Google Scholar
• MITOMI H, MIKAMI T, TAKAHASHI H et al.: Colitis in chronic granulomatous disease resembling Crohn's disease: comparative analysis of CD68-positive cells between two disease entities. Dig. Dis. Sci. (1999) 44(2):452–456.
   PubMed Web of Science ®Google Scholar
• WINKELSTEIN JA, MARINO MC, JOHNSTON RB JR et al.: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 79 (3) :155–169.
   Google Scholar
• MACEDO F, MCHUGH K, GOLD-BLATT D: Pericardial effusions in two boys with chronic granulomatous disease. Pediatr. Radial (1999) 29(11):820–822.
   PubMed Web of Science ®Google Scholar
• GOLDBLATT D, BUTCHER J, THRASHER AJ, RUSSELL-EGGITT I: Chorioretinal lesions in patients and carriers of chronic granulomatous disease. Pediatr. (1999) 134(6):780–783.
   Web of Science ®Google Scholar
• LIESE J, KLOOS S, JENDROSSEK V et al.: Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.' Pediatr. (2000) 137(5):687–693.
   Web of Science ®Google Scholar
• DORMAN SE, GILL VJ, GALLIN JI, HOLLAND SM: Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin. Infect. Dis. (1998) 26(4):889–894.
   PubMed Web of Science ®Google Scholar
• SEGAL BH, DECARLO ES, KWON-CHUNG KJ et al.: Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) (1998) 77(5):345–354.
   PubMed Web of Science ®Google Scholar
• JABADO N, CASANOVA JL, HADDAD E et al.: Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin. Infect. Dis. (1998) 27(6):1437–1441.
   PubMed Web of Science ®Google Scholar
• ROILIDES E, SIGLER L, BIBASHI E et al.: Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J. Clin. Microbiol (1999) 37(1):18–25.
   PubMed Web of Science ®Google Scholar
• GMUNDER FK, SEGER RA: Chronic granulomatous disease: mode of action of sulfamethoxazolehrimethoprim. Pediatr. Res. (1981) 15(12):1533–1537.
   PubMed Web of Science ®Google Scholar
• SEGER RA, BAUMGARTNER S, TIEFENAUER LX, GMUNDER FK: Chronic granulomatous disease: effect of sulfamethoxazolehrimethoprim on neutrophil microbicidal function. Hely Paediatr. Acta (1981) 36(6):579–588.
   PubMedGoogle Scholar
• JACOBS RE WILSON CB: Activity of antibiotics in chronic granulomatous disease leukocytes. Pediatr. Res. (1983) 17(11):916–919.
   PubMed Web of Science ®Google Scholar
• WEENING RS, KABEL P, PIJMAN P, ROOS D: Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J. Pediatr. (1983) 103(1):127–130.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI Y, AMANO D, UEDA K, KAGOSAKI Y, USUI T: Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim. Eur. Pediatr. (1978) 127(4):247–254.
   PubMed Web of Science ®Google Scholar
• MOUY R, FISCHER A, VILMER E, SEGER R, GRISCELLI C: Incidence, severity, and prevention of infections in chronic granulomatous disease. J. Pediatr. (1989) 114(4, Part 1):555–560.
   Google Scholar
• MARGOLIS DM, MELNICK DA, ALLING DW, GALLIN JI: Trimethoprim sulfamethoxazole prophylaxis in the man-agement of chronic granulomatous disease.I Infect. Dis. (1990) 162(3):723–726.
   Google Scholar
• MOUY R, VEBER F, BLANCHE Set al.: Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J. Pediatr. (1994) 125(6, Part 1):998–1003.
   Google Scholar
• HAROUSSEAU JL, DEKKER AW, STAMATOULLAS-BASTARD A et al.: Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrob. Agents Chemother. (2000) 44(7):1887–1893.
   PubMed Web of Science ®Google Scholar
• BOOGAERTS M, MAERTENS J, VAN HOOF A et al.: Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. Antimicrob. Chemother. (2001) 48(1):97–103.
   Google Scholar
• POTTER M: European experience with oral solution and intravenous itraconazole. Oncology (Duntingt) (2001) 15(11, Suppl. 9):27–32.
   Google Scholar
• EZEKOWITZ RA, DINAUER MC, JAFFE HS, ORKIN SH, NEWBURGER PE: Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl. Med. (1988) 319(3):146–151.
   PubMed Web of Science ®Google Scholar
• CONDINO-NETO A, NEWBURGER PE: Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood (2000) 95(11):3548–3554.
   PubMed Web of Science ®Google Scholar
• ISHIBASHI F, MIZUKAMI T, KANEGASAKI S et al: Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene. Blood (2001) 98(2):436–441.
   PubMed Web of Science ®Google Scholar
• THE INTERNATIONAL CHRONIC GRANULOMATOUS DISEASE COOPERATIVE STUDY GROUP: A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl. J. Med. (1991) 324(8):509–516.
   PubMed Web of Science ®Google Scholar
• MUHLEBACH TJ, FEICKERT HJ, WELTE K, SEGER RA: Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous disease. Eur. Pediatr. (1991) 150(8):575–578.
   PubMed Web of Science ®Google Scholar
• WOODMAN RC, ERICKSON RW, RAE J, JAFFE HS, CURNUTTE JT: Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil coddase activity. Blood (1992) 79(6):1558–1562.
   PubMed Web of Science ®Google Scholar
• MOUY R, SEGER R, BOURQUIN JP et al.: Interferon gamma for chronic granulomatous disease. N Engl. J. Med. (1991) 325(21):1516–1517.
   PubMed Web of Science ®Google Scholar
• WEENING RS, LEITZ GJ, SEGER RA: Recombinant human interferon-gamma in patients with chronic granulomatous disease - European follow up study. Eur. I Pediatr. (1995) 154(4):295–298.
   PubMed Web of Science ®Google Scholar
• GALLIN JI: Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood. Clin. Immunol Imm-unopathol (1991) 61(2, Part 2):S100–5105.
   Google Scholar
• AHLIN A, LARFARS G, ELINDER G, PALMBLAD J, GYLLENHAMMAR H: Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils. Clin. Diagn. Lab. Immunol (1999) 6(3):420–424.
   PubMedGoogle Scholar
• PEMAN J, CANTON E, HERNANDEZ MT, GOBERNADO M: Intraphagorytir killing of Gram-positive bacteria by ciprofloxacin. Antimicrob. Chemother. (1994) 34(6):965–974.
   Google Scholar
• CANTON E, PEMAN J, CABRERA E et al.: Killing of Gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated 02-dependent bactericidal mechanisms. Chemotherapy (1999) 45(4):268–276.
   PubMed Web of Science ®Google Scholar
• SHETTY AK, ARVIN AM, GUTIERREZ KM: Nocardia farcinica pneumonia in chronic granulomatous disease. Pediatrics (1999) 104(4, Part 1):961–964.
   Google Scholar
• SERETI I, HOLLAND SM: Disseminated nocardiosis in a patient with X-linked chronic granulomatous disease and human immunodeficiency virus infection. Clin. Infect. Dis (2001) 33(2):235–239.
   PubMed Web of Science ®Google Scholar
• OZSAHIN H, VON PLANTA M, MULLER I et al.: Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood (1998) 92(8):2719–2724.
   PubMed Web of Science ®Google Scholar
• PASIC S, ABINUN M, PISTIGNJAT B et al.: Aspergillus osteomyelitis in chronic granulomatous disease: treatment with recombinant gamma-interferon and itraconazole. Pediatr. Infect. Dis. J. (1996) 15(9):833–834.
   PubMed Web of Science ®Google Scholar
• SPENCER DA, JOHN P, FERRYMAN SR, WELLER PH, DARBYSHIRE P: Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension. Am. I Respir. Grit. Care Med. (1994) 149(1):239–241.
   PubMed Web of Science ®Google Scholar
• CAILLOT D, BASSARIS H, MCGEER A et al.: Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS. Clin. Infect. Dis (2001) 33(8):e83–e90.
   PubMed Web of Science ®Google Scholar
• KLOSS S, SCHUSTER A, SCHROTEN H, LAMPRECHT J, WAHN V: Control of proven pulmonary and suspected CNS Aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur.j Pediatr. (1991) 150(7):483–485.
   PubMed Web of Science ®Google Scholar
• RYDER NS, LEITNER I: Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med. Mycol. (2001) 39(1):91–95.
   PubMed Web of Science ®Google Scholar
• ARIKAN S, LOZANO-CHIU M, PAETZNICK V, REX JH: In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium species. Antimicrob. Agents Chemother. (2002) 46(1):245–247.
   PubMed Web of Science ®Google Scholar
• LUM LR, TURCO TF, LEONE J: Combination therapy with caspofungin and amphotericin B lipid complex. Am. Health Syst. Pharm. (2002) 59(1):80–81.
   PubMed Web of Science ®Google Scholar
• WALSH TJ, PAPPAS P, WINSTON DJ et al.: Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl. Med. (2002) 346(4):225–234.
   PubMed Web of Science ®Google Scholar
• ••A recent study describing the promisingperformance of voriconazole.
   Google Scholar
• DENNING DW, RIBAUD P, MILPIED N et al.: Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. (2002) 34(5):563–571.
   PubMed Web of Science ®Google Scholar
• ••An open study describing the efficacy of voriconazole in invasive Aspergillosis.
   Google Scholar
• MALMVALL BE, FOLLIN P: Successful interferon-gamma therapy in a chronic granulomatous disease (CGD) patient suffering from Staphylococcus aureushepatic abscess and invasive Candida albicans infection. Scand.J. Infect. Dis. (1993) 25(1):61–66.
   PubMedGoogle Scholar
• CONTE D, FRAQUELLI M, CAPSONI F et al.: Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. Interferon Cytokine Res. (1999) 19(7):705–710.
   PubMed Web of Science ®Google Scholar
• TSUMURA N, AKASU Y, YAMANE H et al.: Aspergillus osteomyelitis in a child who has p67Phcx-deficient chronic granulomatous disease. Kurume Med. (1999) 46(1):87–90.
   PubMedGoogle Scholar
• SAULSBURY FT: Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin. Infect. Dis. (2001) 32(10):E137–E139.
   Web of Science ®Google Scholar
• ••An interesting new approach to increasingNADPH oxidase function in neutrophils.
   Google Scholar
• GERBER CE, BRUCHELT G, FALK UB et al.: Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-wddase-containing liposomes. Blood (2001) 98(10):3097–3105.
   PubMed Web of Science ®Google Scholar
• STRAUSS RG: Clinical perspectives of granulocyte transfusions: efficacy to date. Clin. Apheresis. (1995) 10(3):114–118.
   PubMed Web of Science ®Google Scholar
• QUIE PG: The white cells: use of granulocyte transfusions. Rev Infect. Dis. (1987) 9(1):189–193.
   PubMedGoogle Scholar
• VON PLANTA M, OZSAHIN H, SCHROTEN H, STAUFFER UG, SEGER RA: Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease. Eur: .1. Pediatr. Surg. (1997) 7(4):234–236.
   Google Scholar
• LEKSTROM-HIMES JA, HOLLAND SM, DECARLO ES et al.: Treatment with intralesional granulocyte instillations and interferon-gamma for a patient with chronic granulomatous disease and multiple hepatic abscesses. Clin. Infect. Dis. (1994) 19(4):770–773.
   PubMed Web of Science ®Google Scholar
• PRICE TH: The use of G-CSF in normal neutrophil donors. Ann. Med. Interne (Paris) (2000) 151(2):115–122.
   PubMedGoogle Scholar
• STRONCEK DF, LEONARD K, EIBER G et al.: Alloimmunization after granulocyte transfusions. Transfusion (1996)36(11-12):1009–1015.
   PubMed Web of Science ®Google Scholar
• SCHAPPI MG, SMITH VV, GOLD-BLATT D, LINDLEY KJ, MILLA PJ: Colitis in chronic granulomatous disease. Arch. Dis. Child (2001) 84(2):147–151.
   PubMed Web of Science ®Google Scholar
• ROSH JR, TANG HB, MAYER L et al.: Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. Pediatr. (1995) 126(1):143–145.
   Web of Science ®Google Scholar
• BARTON LL, MOUSSA SL, VILLAR RG, HULETT RL: Gastrointestinal comp-lications of chronic granulomatous disease: case report and literature review. Clin. Pediatr. (Phila.) (1998) 37(4):231–236.
   PubMed Web of Science ®Google Scholar
• NIELSEN H, VALERIUS NH: Thalidomide enhances superoxide anion release from human polymorphonuclear and mononuclear leukocytes. Acta Pathol Microbial. Immunol Scand. (C.) (1986) 94(6):233–237.
   Google Scholar
• MYRUP B, VALERIUS NH, MORTENSEN PB: Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut (1998) 42(1):127–130.
   PubMed Web of Science ®Google Scholar
• PRESENT DH, RUTGEERTS P, TARGAN S et al.: Infliximab for the treatment of fistulas in patients with Crohn's disease. N EngL I Med. (1999) 340(18):1398–1405.
   PubMed Web of Science ®Google Scholar
• CHIN TW, STIEHM ER, FALLOON J, GALLIN JI: Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J. Pediatr. (1987) 111(3):349–352.
   PubMed Web of Science ®Google Scholar
• AL TAWIL YS, ABRAMSON SL, GILGER MA, PAUL ME: Steroid-responsive esophageal obstruction in a child with chronic granulomatous disease (CGD). Pediatr. Gastroenterol Nutt (1996) 23(2):182–185.
   PubMed Web of Science ®Google Scholar
• COLLMAN RJ, DICKERMAN JD: Corticosteroids in the management of cystitis secondary to chronic granulomatous disease. Pediatrics (1990) 85(2):219–221.
   PubMed Web of Science ®Google Scholar
• FINN A, HADZIC N, MORGAN G, STROBEL S, LEVINSKY RJ: Prognosis of chronic granulomatous disease. Arch. Dis. Child. (1990) 65(9):942–945.
   PubMed Web of Science ®Google Scholar
• HASUI M: Chronic granulomatous disease in Japan: incidence and natural history. The study group of phagocyte disorders of Japan. Pediatr. Int. (1999) 41(5):589–593.
   Google Scholar
• LEUNG T, CHIK K, LI C, SHING M, YUEN P: Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature. Bone Marrow Transplant. (1999) 24(5):567–570.
   PubMed Web of Science ®Google Scholar
• HORWITZ ME, BARRETT AJ, BROWN MR et al: Treatment of chronic granulomatous disease with non-myoablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl. Med. (2001) 344(12):881–888.
   PubMed Web of Science ®Google Scholar
• CAVAZZANA-CALVO M, HACEIN-BEY S, DE SAINT BG et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 288(5466):669–672.
   Google Scholar
• BJORGVINSDOTTIR H, DING C, PECH N et al: Retroviral-mediated gene transfer of gp91P1'" into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood (1997) 89(1):41–48.
   PubMed Web of Science ®Google Scholar
• MARDINEY M, III, JACKSON SH, SPRATT SK et al.: Enhanced host defense after gene transfer in the murine p47P1'x-deficient model of chronic granulomatous disease. Blood(1997) 89(7):2268–2275.
   PubMed Web of Science ®Google Scholar
• MALECH HL, MAPLES PB, WHITING-THEOBALD N et al.: Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc. Nati Acad. Sci. USA (1997) 94(22):12133–12138.
   PubMed Web of Science ®Google Scholar
• ••The first report of gene therapy in patientsaffected with CGD.
   Google Scholar